Suzhou Zelgen Biopharmaceuticals Co.,Ltd
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Suzhou Zelgen Biopharmaceuticals Co.,Ltd
RECRUITINGPhase 1 / Phase 2NCT07038096
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
This study is a randomized, multicenter, Phase Ib/II clinical trial, aimed at evaluating the efficacy and safety of the combination of ZG006 and ZG005 in patients with advanced...
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,LtdEnrolling: 3501 location
Small Cell Lung CancerNeuroendocrine Carcinoma
RECRUITINGPhase 1 / Phase 2NCT06903377
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
This is a multicenter Phase I/II study for patients with advanced non-small cell lung cancer who have failed PD-1/L1 therapy, aiming to evaluate the safety of ZG005 in combination...
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,LtdEnrolling: 501 location
Non-small Cell Lung Cancer
RECRUITINGPhase 2NCT06558227
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular...
This study is a randomized, open-label, positive-controlled, multicenter phase II clinical trial. It evaluates the efficacy and safety of ZG005 combined with Bevacizumab compared...
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,LtdEnrolling: 901 location
Hepatocellular Carcinoma